RECRUITING

Generating Advancements Through Longitudinal Analysis in X and Y Variations (GALAXY)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

GALAXY is a registry research study that plans to learn more about individuals with X\&Y variations (also called sex chromosome aneuploidies) through collecting information from medical records.This includes genetic tests, imaging, medications, and more for hundreds of patients seen at a number of clinics across the US. The purpose of the GALAXY Registry is to collect and store this information with the overall goal to improve health outcomes in individuals with X\&Y variations and the care they receive.

Official Title

Generating Advancements Through Longitudinal Analysis in X and Y Variations

Quick Facts

Study Start:2022-04-28
Study Completion:2037-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06373861

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:0 Days to 100 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD, ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Genetically-confirmed diagnosis of a sex chromosome aneuploidy condition
  2. 2. Any age
  3. 3. Any gender
  4. 4. Informed consent for individuals \>18 years of age, parent/guardian permission for individuals \<18 or proxy-consent from legally authorized representative if impaired decision making
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Shanlee M Davis, MD, PhD
CONTACT
720-777-6073
shanlee.davis@childrenscolorado.org

Principal Investigator

Shanlee M Davis, MD, PhD
PRINCIPAL_INVESTIGATOR
Children's Hospital Colorado

Study Locations (Sites)

Children's Hospital Colorado
Aurora, Colorado, 80045
United States

Collaborators and Investigators

Sponsor: University of Colorado, Denver

  • Shanlee M Davis, MD, PhD, PRINCIPAL_INVESTIGATOR, Children's Hospital Colorado

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-04-28
Study Completion Date2037-04

Study Record Updates

Study Start Date2022-04-28
Study Completion Date2037-04

Terms related to this study

Keywords Provided by Researchers

  • X&Y variations
  • chromosome variations
  • Klinefelter
  • XXY
  • XXX
  • XYY
  • tetrasomy
  • pentasomy
  • trisomy

Additional Relevant MeSH Terms

  • Sex Chromosome Aneuploidy